Lalit Kumar
Impact in
- Pharmaceutical Science top 0.2%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Cancer Research top 2%
- MicroRNA in disease regulation
Papers in
-
- Advanced Drug Delivery Systems 37
- Drug Solubulity and Delivery Systems 29
- Advancements in Transdermal Drug Delivery 29
- Co-authors
- Ruchi Verma (43 shared papers)Shivam Prakash Gautam (9 shared papers)Shubhrata Gupta (9 shared papers)Rupesh Kalidas Shirodkar (35 shared papers)Shamsuzzama Shamsuzzama (11 shared papers)Salwa (20 shared papers)Aamir Nazir (7 shared papers)Navya Ajitkumar Bhaskaran (16 shared papers)
- Journals
- Journal of Clinical Oncology (12 papers)Annals of Hematology (7 papers)Journal of Drug Delivery Science and Technology (6 papers)Journal of Pharmaceutical Innovation (5 papers)European Journal of Medicinal Chemistry (5 papers)
- Partner nations
- IndiaUnited StatesAustralia
In The Last Decade
Lalit Kumar
413 papers receiving 7.0k citations
Lalit Kumar's Hit Papers
Peers
Comparison fields: 5 of 195
- Pharmaceutical Science 825
- Cancer Research 614
- Hematology 428
- Biomaterials 375
- Automotive Engineering 335
Countries citing papers authored by Lalit Kumar
This map shows the geographic impact of Lalit Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lalit Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lalit Kumar more than expected).
Fields of papers citing papers by Lalit Kumar
This network shows the impact of papers produced by Lalit Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lalit Kumar. The network helps show where Lalit Kumar may publish in the future.
Co-authors
The 25 scholars most cited alongside Lalit Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 458 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 3D Printing as a Promising Tool in Personalized Medicine Hit paper breakdown → | 2021 | 313 |
| 2 | 2019 | 219 | |
| 3 | 2016 | 164 | |
| 4 | 2018 | 128 | |
| 5 | 2010 | 126 | |
| 6 | 2022 | 121 | |
| 7 | 2023 | 114 | |
| 8 | 2015 | 109 | |
| 9 | 2010 | 109 | |
| 10 | 1999 | 102 | |
| 11 | 1975 | 97 | |
| 12 | 2016 | 96 | |
| 13 | 2019 | 93 | |
| 14 | 2014 | 92 | |
| 15 | 2018 | 88 | |
| 16 | 2018 | 88 | |
| 17 | 2016 | 82 | |
| 18 | 2015 | 77 | |
| 19 | 2018 | 76 | |
| 20 | 2009 | 71 |
About Lalit Kumar
Lalit Kumar is a scholar working on Molecular Biology, Pharmaceutical Science, Pathology and Forensic Medicine, Oncology and Hematology, having authored 458 papers that have together received 7.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (41 papers), Advanced Drug Delivery Systems (37 papers), Analytical Methods in Pharmaceuticals (32 papers), Drug Solubulity and Delivery Systems (29 papers), Advancements in Transdermal Drug Delivery (29 papers), Chronic Lymphocytic Leukemia Research (26 papers), Multiple Myeloma Research and Treatments (23 papers) and Analytical Chemistry and Chromatography (18 papers). The work is most often cited by research in Pharmaceutical Science (825 citations), Cancer Research (614 citations), Hematology (428 citations), Biomaterials (375 citations) and Automotive Engineering (335 citations). Lalit Kumar has collaborated with scholars based in India, United States and Australia. Frequent co-authors include Ruchi Verma, Shivam Prakash Gautam, Shubhrata Gupta, Rupesh Kalidas Shirodkar, Shamsuzzama Shamsuzzama, Salwa, Aamir Nazir, Navya Ajitkumar Bhaskaran, Rizwanul Haque and Atul Sharma. Their work appears in journals such as Journal of Clinical Oncology, Annals of Hematology, Journal of Drug Delivery Science and Technology, Journal of Pharmaceutical Innovation and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.